TargetMol

CFTR(inh)-172

Product Code:
 
TAR-T2355
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2355-1mg1mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2355-2mg2mg£101.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2355-5mg5mg£119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2355-1mL1 mL * 10 mM (in DMSO)£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2355-10mg10mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2355-25mg25mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2355-50mg50mg£374.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2355-100mg100mg£519.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
CFTRinh-172 is a voltage-independent, selective CFTR inhibitor.
CAS:
307510-92-5
Formula:
C18H10F3NO3S2
Molecular Weight:
409.4
Pathway:
Autophagy; Membrane transporter/Ion channel
Purity:
0.9994
SMILES:
OC(=O)c1ccc(C=C2SC(=S)N(C2=O)c2cccc(c2)C(F)(F)F)cc1
Target:
CFTR; Autophagy

References

1. Ma T, et al. J Clin Invest. 2002, 110(11), 1651-1658. 2. Lu M, et al. Curr Eye Res. 2012, 37(8), 671-677. 3. Kelly M, et al. J Pharmacol Exp Ther. 2010, 333(1), 60-69. 4. Sawasvirojwong S, et al. PLoS Negl Trop Dis. 2013, 7(6), e2293.